MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Geschlossen

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.87

Max

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.3M -3M
Verkäufe	100K 100K
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	531K 40M
Vorheriger Eröffnungskurs	5
Vorheriger Schlusskurs	5

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Apr. 2026, 17:26 UTC

Wichtige Nachrichtenereignisse

EIA Raises Oil-Price Forecasts as War in Middle East Continues

7. Apr. 2026, 23:55 UTC

Market Talk

Genesis Energy Signals Higher Dividend Payout Ratios -- Market Talk

7. Apr. 2026, 23:47 UTC

Market Talk

Wichtige Nachrichtenereignisse

Market Talk Roundup: Latest on U.S. Politics

7. Apr. 2026, 23:47 UTC

Market Talk

Wichtige Nachrichtenereignisse

Precious Metals Rise, Boosted by Dollar Weakness, Lower Treasury Yields -- Market Talk

7. Apr. 2026, 23:44 UTC

Market Talk

Wichtige Nachrichtenereignisse

Gold Rallies as Trump Remarks Send Oil Prices Lower -- Market Talk

7. Apr. 2026, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

7. Apr. 2026, 23:42 UTC

Market Talk

Nikkei Likely to Rise After Trump Agrees to Cease-Fire With Iran -- Market Talk

7. Apr. 2026, 23:37 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Futures Fall After Trump Agrees to Two-Week Cease-Fire With Iran -- Market Talk

7. Apr. 2026, 23:15 UTC

Market Talk

Wichtige Nachrichtenereignisse

Markets Will Want Fast Evidence That Ships Are Moving -- Market Talk

7. Apr. 2026, 23:04 UTC

Wichtige Nachrichtenereignisse

Spot Gold Rises 2.5%, Spot Silver Climbs 4.9%

7. Apr. 2026, 23:04 UTC

Wichtige Nachrichtenereignisse

Precious Metals Rise After Trump Agrees to Ceasefire With Iran

7. Apr. 2026, 23:03 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. Apr. 2026, 23:03 UTC

Market Talk

Middle East Ceasefire Triggers Australian Dollar Rally -- Market Talk

7. Apr. 2026, 23:01 UTC

Wichtige Nachrichtenereignisse

Front-Month WTI Crude Oil Futures Falls 13.7% to $97.47 per Barrel

7. Apr. 2026, 22:58 UTC

Wichtige Nachrichtenereignisse

Front-Month Crude Oil Futures Slide After Trump Agrees to Cease-Fire With Iran

7. Apr. 2026, 21:56 UTC

Akquisitionen, Fusionen, Übernahmen

Telefónica Sells All Shares in Pegaso PCS, Celular de Telefonía

7. Apr. 2026, 20:50 UTC

Market Talk

Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

7. Apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7. Apr. 2026, 19:45 UTC

Market Talk

Treasury Yields Mixed as Investors Brace for Iran Deadline -- Market Talk

7. Apr. 2026, 19:17 UTC

Wichtige Nachrichtenereignisse

The Risks to the Gulf Region's Oil Are Immense. Are Markets Shrugging Them Off? -- Barrons.com

7. Apr. 2026, 19:16 UTC

Market Talk

Cold Shot Helps U.S. Natural Gas Futures Settle Higher -- Market Talk

7. Apr. 2026, 19:07 UTC

Market Talk

Global Energy Roundup: Market Talk

7. Apr. 2026, 19:07 UTC

Market Talk

Oil Futures Mixed Ahead of Trump's Iran Deadline -- Market Talk

7. Apr. 2026, 18:41 UTC

Akquisitionen, Fusionen, Übernahmen

Eldorado Gold: Total of 149.6M Common Shrs, Representing 75.31% of Votes Attached to All Outstanding Common Shrs, Were Voted >ELD.T

7. Apr. 2026, 18:40 UTC

Akquisitionen, Fusionen, Übernahmen

Eldorado Gold Holders Voted to Approve Issuance of Common Shrs in Connection With Proposed Plan of Arrangement With Foran Mining >ELD.T

7. Apr. 2026, 18:39 UTC

Akquisitionen, Fusionen, Übernahmen

Eldorado Gold Reports Voting Results From Special Meeting of Hldrs

7. Apr. 2026, 18:24 UTC

Wichtige Nachrichtenereignisse

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7. Apr. 2026, 17:08 UTC

Market Talk

Latin America Less Exposed to Crude Supply Disruptions -- Market Talk

7. Apr. 2026, 16:21 UTC

Wichtige Nachrichtenereignisse

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7. Apr. 2026, 16:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.